78 related articles for article (PubMed ID: 1731040)
1. Effect of long-acting calcium entry blocker (anipamil) on blood pressure, renal function and survival of uremic rats.
Jarusiripipat C; Chan L; Shapiro JI; Schrier RW
J Pharmacol Exp Ther; 1992 Jan; 260(1):243-7. PubMed ID: 1731040
[TBL] [Abstract][Full Text] [Related]
2. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
Lebel M; Rodrigue ME; Agharazii M; Larivière R
Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
[TBL] [Abstract][Full Text] [Related]
3. The control of hypertension and its effect on renal function in rat remnant kidney.
Eliahou HE; Cohen D; Herzog D; Shechter P; Serban I; Kapuler S; Schiby G; Gavendo S
Nephrol Dial Transplant; 1988; 3(1):38-44. PubMed ID: 3132638
[TBL] [Abstract][Full Text] [Related]
4. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
Ishimitsu T; Honda T; Ohta S; Akashiba A; Takahashi T; Kameda T; Yoshii M; Minami J; Takahashi M; Ono H; Matsuoka H
Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768
[TBL] [Abstract][Full Text] [Related]
5. Long acting calcium antagonist anipamil limits myocardial necrosis and penetrates the ischemic zone during 24 h of coronary artery occlusion in the dog.
Denniss AR; Kingma JG; Hearse DJ; Downey JM; Yellon DM
Can J Cardiol; 1990; 6(1):31-7. PubMed ID: 2310993
[TBL] [Abstract][Full Text] [Related]
6. In vivo anti-platelet properties of anipamil, a calcium channel blocker, in the rabbit.
Osborne JA; Darius H; Lefer AM
Res Commun Chem Pathol Pharmacol; 1986 May; 52(2):167-78. PubMed ID: 3715198
[TBL] [Abstract][Full Text] [Related]
7. NTP Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CAS No. 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 423():1-336. PubMed ID: 12616288
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of captopril and enalapril on the progression of chronic renal disease in partially nephrectomized rats.
Fettman MJ; Wilke WL; VanHouten DS; Hamar DW; Mikita DJ
Res Commun Chem Pathol Pharmacol; 1989 Aug; 65(2):131-46. PubMed ID: 2555851
[TBL] [Abstract][Full Text] [Related]
9. NTP Toxicology and Carcinogenesis Studies of Phenolphthalein (CAS No. 77-09-8) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Nov; 465():1-354. PubMed ID: 12579199
[TBL] [Abstract][Full Text] [Related]
10. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
11. Effect of pretreatment with anipamil on a submaximal calcium paradox in the isolated rat heart.
Ruigrok TJ; Kirkels JH
Cardioscience; 1990 Sep; 1(3):213-6. PubMed ID: 2102810
[TBL] [Abstract][Full Text] [Related]
12. Disparate effects of angiotensin converting enzyme inhibitor and calcium blocker treatment on the preservation of renal structure and function following subtotal nephrectomy or streptozotocin-induced diabetes in the rat.
Jackson B; Cubela R; Debrevi L; Whitty M; Johnston CI
J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S167-9. PubMed ID: 2455124
[TBL] [Abstract][Full Text] [Related]
13. Effects of probucol in renal function and structure in rats with subtotal kidney ablation.
Modi KS; Schreiner GF; Purkerson ML; Klahr S
J Lab Clin Med; 1992 Aug; 120(2):310-7. PubMed ID: 1500828
[TBL] [Abstract][Full Text] [Related]
14. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
15. Cardioprotective actions of a new calcium channel blocker in acute myocardial ischemia.
Brezinski ME; Darius H; Lefer AM
Arzneimittelforschung; 1986 Mar; 36(3):464-6. PubMed ID: 3707665
[TBL] [Abstract][Full Text] [Related]
16. Effects of protease therapy in the remnant kidney model of progressive renal failure.
Sebekova K; Paczek L; Dämmrich J; Ling H; Spustova V; Gaciong Z; Heidland A
Miner Electrolyte Metab; 1997; 23(3-6):291-5. PubMed ID: 9387136
[TBL] [Abstract][Full Text] [Related]
17. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure].
Ciechanowicz A
Ann Acad Med Stetin; 1999; Suppl 52():1-93. PubMed ID: 10589103
[TBL] [Abstract][Full Text] [Related]
18. [Are all antihypertensive drugs renoprotective?].
Wolf S; Risler T
Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
[TBL] [Abstract][Full Text] [Related]
19. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
20. Effects of chronic administration of somatostatin analogue SMS 201-995 on the progression of chronic renal failure in subtotal nephrectomized rats.
Uemasu J; Tokumoto A; Godai K; Kawasaki H; Hirayama C
Exp Clin Endocrinol; 1990 Sep; 96(1):97-104. PubMed ID: 2279532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
